We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.01T
AUM Growth
+$82B
Cap. Flow
+$21.4B
Cap. Flow %
2.11%
Top 10 Hldgs %
17.99%
Holding
7,861
New
173
Increased
3,407
Reduced
3,131
Closed
203

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.06B
2
AMZN icon
Amazon
AMZN
+$1.51B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.42B
4
TSLA icon
Tesla
TSLA
+$1.17B
5
MSFT icon
Microsoft
MSFT
+$997M

Sector Composition

Rank Sector Weight
1 Technology 20.98%
2 Healthcare 10.48%
3 Financials 9.86%
4 Consumer Discretionary 8.78%
5 Industrials 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UWM icon
5326
ProShares Ultra Russell2000
UWM
$240M
$282K ﹤0.01%
8,210
+8,199
+74,536% +$258K
CARM
5327
DELISTED
Carisma Therapeutics
CARM
$282K ﹤0.01%
32,193
+25,447
+377% +$139K
BHRB icon
5328
Burke & Herbert Financial Services Corp
BHRB
$1.49B
$282K ﹤0.01%
+4,393
New +$345K
GMDA
5329
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$281K ﹤0.01%
145,733
+43,738
+43% +$75.3K
ICLO icon
5330
Invesco AAA CLO Floating Rate Note ETF
ICLO
$526M
$280K ﹤0.01%
+11,000
New +$281K
KRT icon
5331
Karat Packaging
KRT
$814M
$280K ﹤0.01%
15,348
+1,755
+13% +$27.1K
CAN
5332
Canaan Creative
CAN
$132M
$280K ﹤0.01%
131,428
+8,880
+7% +$21.5K
PRAX icon
5333
Praxis Precision Medicines
PRAX
$8.52B
$279K ﹤0.01%
16,200
-39,036
-71% -$598K
HLGN
5334
DELISTED
Heliogen, Inc.
HLGN
$279K ﹤0.01%
32,569
+13,357
+70% +$122K
EMM icon
5335
Global X Emerging Markets ex-China ETF
EMM
$54M
$277K ﹤0.01%
+10,916
New +$276K
CGGR icon
5336
Capital Group Growth ETF
CGGR
$24.6B
$277K ﹤0.01%
10,992
+1,035
+10% +$24.1K
KNTE
5337
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$277K ﹤0.01%
91,301
+50,677
+125% +$195K
KOLD icon
5338
ProShares UltraShort Bloomberg Natural Gas
KOLD
$95.6M
$276K ﹤0.01%
9,964
+3,616
+57% +$131K
FLXS icon
5339
Flexsteel Industries
FLXS
$317M
$275K ﹤0.01%
14,409
-383
-3% -$6.94K
VRCA icon
5340
Verrica Pharmaceuticals
VRCA
$90.2M
$275K ﹤0.01%
4,768
-11,671
-71% -$709K
AKYA
5341
DELISTED
Akoya BioSciences
AKYA
$275K ﹤0.01%
37,220
+7,370
+25% +$49.2K
PLX icon
5342
Protalix BioTherapeutics
PLX
$187M
$275K ﹤0.01%
137,297
+55,121
+67% +$131K
BUFR icon
5343
FT Vest Fund of Buffer ETFs
BUFR
$10.2B
$274K ﹤0.01%
10,950
+551
+5% +$13.2K
AMSC icon
5344
American Superconductor
AMSC
$1.5B
$272K ﹤0.01%
43,499
-11,415
-21% -$55.6K
BIO.B icon
5345
Bio-Rad Laboratories Class B
BIO.B
$9.02B
$272K ﹤0.01%
724
TAYD icon
5346
Taylor Devices
TAYD
$169M
$272K ﹤0.01%
10,638
+1,380
+15% +$29.1K
STIX
5347
DELISTED
Semantix, Inc. Class A Ordinary Shares
STIX
$271K ﹤0.01%
103,216
-800
-0.8% -$2.56K
TCRX icon
5348
TScan Therapeutics
TCRX
$47.3M
$271K ﹤0.01%
108,475
-22,844
-17% -$61.3K
PDEX icon
5349
Pro-Dex
PDEX
$203M
$268K ﹤0.01%
14,050
+4,700
+50% +$81.8K
MKTW icon
5350
MarketWise
MKTW
$53.6M
$268K ﹤0.01%
6,701
+538
+9% +$21.1K

Similar funds

Morgan Stanley's Q2 2023 Portfolio in Review

As of Q2 2023, Morgan Stanley held 7,861 positions worth $1.01T, up 8.8% from $933B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 4.8%. Morgan Stanley opened 173 new positions and exited 203, leaving the 7,861-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 3,490,516 shares worth $87.1M.
  • Morgan Stanley added most to NVIDIA in Q2 2023, an estimated $2.06B increase.
  • Morgan Stanley's biggest Q2 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $724M.
  • Morgan Stanley fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $925M.
  • Morgan Stanley's ten largest holdings make up 18% of its $1.01T portfolio in Q2 2023.
  • Morgan Stanley opened 173 new positions and closed 203 in Q2 2023.
  • Morgan Stanley's portfolio value rose 8.8% quarter-over-quarter to $1.01T.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.